openPR Logo
Press release

European Nations Fall Behind US in IVF Pregnancy Rates

02-07-2012 02:53 AM CET | Health & Medicine

Press release from: Center for Human Reproduction

February 6, 2012 (New York, NY) – Recent reports of plateauing IVF pregnancy rates in Europe are in stark contrast to still-rising rates in the US, according to Norbert Gleicher, M.D., a prominent fertility expert and Medical Director of the Center for Human Reproduction (CHR) in New York City. Behind this difference may be a fundamental difference in approaches to the patient-physician relationship in Europe and the US.

Focus on Reproduction, the official magazine of the European Society for Human Reproduction and Embryology (ESHRE), recently reported that in Europe overall IVF pregnancy rates have leveled off.

As first reported by Dr. Gleicher’s team in 2006(1,2), European IVF pregnancy rates are significantly lower than American rates. The most recent European data show clinical pregnancy rate per cycle of 32.5%. Conservatively assuming a miscarriage rate of 15%, this would translate into delivery rates of 26.6%. During the same time period, the US delivery rate was 40.7%.

The question is why.

“A part of the reason is the recent propagation of single-embryo transfer (sET) in Europe,” explains Dr. Gleicher. “In Europe, fertility experts and governments alike consider the reduced risk of multiple pregnancies through sET a good enough reason to offset lower pregnancy chances caused by sET. Thus, many European countries mandate sET despite irrefutable evidence that patients value nothing more than better chances of pregnancy in choosing their infertility treatments.

“This is a good example for the fundamental difference in the socio-medical philosophy between Europe and the US,” points out Dr. Gleicher: “Europe values what they perceive as the ‘common good’ over individual rights of patients. What they fail to recognize, however, are the unintended consequences affecting the patient-physician relationship and, most importantly, IVF outcomes.”

He continues: “Not only do patients end up with much lower pregnancy chances with IVF than their U.S. counterparts, they, in the end, are also forced to undergo more IVF cycles , at more cost, and, of course, more risks.” Europe, therefore, performs more than three-times as many IVF cycles per capita than the US. The same philosophy in Europe also results in outright rationing. For example, most Scandinavian countries withhold all IVF treatment from women above age 40-41, an approach unthinkable in the US.

“If there is a lesson to be learned here,” says Dr. Gleicher, “it is that IVF pregnancy rates in the U.S. will continue to improve, as long as IVF research and clinical care remain largely unaffected by government interference, and primarily driven by success in the marketplace, as they have over the last few decades.”

(1)Gleicher et al. A formal comparison of the practice of assisted reproductive technologies between Europe and the USA. Hum Reprod 2006;21:1945-50; (2)Gleicher et al. Update on the comparison of assisted reproduction outcomes between Europe and the USA: the 2002 data Fertil Steril 2007;87:1301-5.

About Center for Human Reproduction
Center for Human Reproduction, or CHR (hhttp://www.centerforhumanreprod.com), is a leading fertility center in the United States with a worldwide reputation as a "fertility center of last resort," specializing in treatment of infertility in women with diminished ovarian reserve. Under the leadership of Dr. Norbert Gleicher, CHR has been helping many European patients—in addition to local New York and North American patients—receive state-of-the-art fertility treatments. Dr. Gleicher is available for additional comments.

http://www.centerforhumanreprod.com
Communications Manager
Center for Human Reproduction
212-994-4400 x.4491
webadmin@thechr.com
21 E. 69th Street
New York, NY 10021
Phone:(212) 994-4400
Fax:(212) 994-4499

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release European Nations Fall Behind US in IVF Pregnancy Rates here

News-ID: 209880 • Views:

More Releases from Center for Human Reproduction

IVF Success Rates Not Improved by Preimplantation Genetic Screening, According to CHR Research
IVF Success Rates Not Improved by Preimplantation Genetic Screening, According t …
There is no evidence that recent technical improvements in preimplantation genetic screening (PGS) improve IVF pregnancy chances, according to a paper just published online in the Journal of Assisted Reproduction and Genetics1. The review, by two fertility specialists from New York’s Center for Human Reproduction (CHR), raises important questions, as this “new” PGS is actively marketed to patients as “proven” and “established” to increase IVF success rates. In the late ‘90s,
Research from CHR Offers Hope for Women with Treatment-Resistant Thin Endometrium
Research from CHR Offers Hope for Women with Treatment-Resistant Thin Endometriu …
November 15, 2012 (New York, NY) – Direct perfusion of the endometrial cavity with granulocyte colony-stimulating factor (G-CSF) improves the thickness of the endometrial lining in IVF patients with too thin endometrium even after treatments, according to a new study just published online in the medical journal Human Reproduction(1). In the study, 21 women undergoing in vitro fertilization (IVF) cycles at the Center for Human Reproduction (CHR) in New York City
FMR1 Gene May Control Women’s Fertility Life Cycle, According to Research
FMR1 Gene May Control Women’s Fertility Life Cycle, According to Research
October 23, 2012 (New York, NY) – A new study presented at the Annual Meeting of the American Society for Reproductive Medicine (ASRM) in San Diego, CA, offers further evidence that the fragile X mental retardation 1 gene (FMR1 gene) may play an important role in controlling women’s fertility life cycles. The study, conducted by researchers from the Center for Human Reproduction (CHR), a leading fertility center in New York
BRCA1/2 Mutation and FMR1 Gene Study Has Potential Implications for Cancer Screening and Treatment
BRCA1/2 Mutation and FMR1 Gene Study Has Potential Implications for Cancer Scree …
BRCA1/2 gene mutations, widely associated with breast and ovarian cancer risks in women, are, in principle, lethal to human embryos, according to new research conducted by three teams of researchers from the Center for Human Reproduction (CHR) in New York City, the Medical University Vienna in Vienna, Austria, and the Medical University Graz, Graz, Austria. BRCA1/2-positive embryos will only survive when also carrying a specific FMR1 gene genotype. In a paper

All 4 Releases


More Releases for Europe

2019 Strategy Consulting Market Analysis | McKinsey, The Boston Consulting Group …
Strategy Consulting Market reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion, acquisition, and new product launch as well as analyzing and understanding the market trends Need for strategic planning in highly competitive environment and to develop business capabilities to meet & exceed the emerging requirements are the major drivers which help in surging
Strategy Consulting Market 2025 | Analysis By Top Key Players: Booz & Co. , Rola …
Global Strategy Consulting Market 2019-2025, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The key players covered in this study McKinsey , The Boston Consulting Group , Bain & Company , Booz & Co. , Roland Berger Europe
Digital Strategy Consulting Market is Thriving Worldwide with Deloitte, McKinsey …
A Digital Strategy is a form of strategic management and a business answer or response to a digital question, often best addressed as part of an overall business strategy. A digital strategy is often characterized by the application of new technologies to existing business activity and focus on the enablement of new digital capabilities to their business. A new report as a Digital Strategy Consulting market that includes a comprehensive analysis
Strategy Consulting Market 2019: By McKinsey, The Boston Consulting Group, Bain …
This report studies the global Strategy Consulting market, analyzes and researches the Strategy Consulting development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like • McKinsey • The Boston Consulting Group • Bain & Company • Booz & Co. • Roland Berger Europe • Oliver Wyman Europe • A.T. Kearney Europe • Deloitte • Accenture Europe Get Sample Report@ https://www.reporthive.com/enquiry.php?id=1247388&req_type=smpl&utm_source=AB Market segment by Type, the product can be split into • Operations Consultants • Business Strategy Consultants • Investment Consultants • Sales and
Strategy Consulting Market Analysis 2018: McKinsey, The Boston Consulting Group, …
Orbis Research Present’s “Global Strategy Consulting Market” magnify the decision making potentiality and helps to create an effective counter strategies to gain competitive advantage. The global Strategy Consulting status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Strategy Consulting development in United States, Europe and China. In 2017, the global Strategy Consulting market size was million US$ and it is expected to reach million
Influenza Vaccination Market Global Forecast 2018-25 Estimated with Top Key Play …
UpMarketResearch published an exclusive report on “Influenza Vaccination market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Influenza Vaccination market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This